CBSET News
2026
CBSET builds 110,000-square-foot Waltham facility to triple capacity, house foriegn biotechs
Cilcare steps up its US expansion: Clinical trial at MGH, threefold capacity growth with CBSET, and launch of a gateway for foreign biotechs entering the American market
CBSET Expands Leadership Team, Welcoming Michael C. John as Chief Regulatory and Innovation Officer (CRIO)
2025
Press Release: Arlington Capital Partners Announces Majority Growth Investment in CBSET
Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System
CBSET playing a key role in advancing biomedical innovation in Massachusetts
DeepQure Presents Laparoscopic RDN Research Results at CRT 2025
2024
2023
2022
Interview with Hearing Health Matters: New Medical Approaches to Treating Hearing Loss
Press Release: CILcare-CBSET receive Hearing Technology Innovator Awards for their cutting-edge preclinical auditory services in therapeutics category
Press Release: Preclinical Study Provides Guidance for Optimizing Safety and Efficacy of Endovascular Hepatic Denervation Devices to Treat Diabetes
Best Practices for the Conduct of Preclinical Ototoxicity Evaluation: ACT Talking Tox replay
2021
MD+DI: COVID-19 One Year Later: Can’t Keep a Medical Device Startup Down
Press Release: CBSET-CILcare to report experimental methodologies for performing cochlear implant studies in anatomically relevant large species at the ‘ARO 2021 Virtual Midwinter Meeting’
Cardiovascular News: FLEX Vessel Prep™ System Data Presented During Leipzig Interventional Course (LINC) 2021
Press Release: Mathieu Schué joins CILcare as Project Director of Drug Development and Translational Research
2020
Press Release: CBSET partner CILcare opens new subsidiary in Denmark
Endovascular Today: CBSET Preclinical Study Shows Balloon-Based Drug Delivery Is Critically Dependent on Coating Micromorphology
Press Release: Preclinical studies reveal balloon-based drug delivery to be critically dependent on coating micro-morphology, suggesting a paradigm for accelerated treatment optimization
Press Release: CILcare-CBSET nominated for the prestigious PRIX Galien Medstartup award in the ‘Best Collaboration Dedicated to the Developing or Underserved Populations Worldwide’ Category
Medical Alley: COVID-19 and Quarantine – Can’t keep a medical device start-up down
Press Release: CILcare enhances its regulatory expertise with Marie-Pierre Pasdelou’s appointment as Chief Regulatory Officer
Press Release: CILcare extends its expertise to develop solutions for people with vestibular disorders with its partner Vertidiag
Press Release: CBSET Partner CILcare Promotes Dr. Cyrille Sage to Director of U.S. Operations
Press Release: CBSET partner CILcare promotes Dr. Wahid Awad to Chief Business Officer and elects him to Board of Directors
Press Release: CBSET-CILcare to report experimental methodologies for performing translational auditory research in pigs and sheep at the ‘ARO Midwinter Meeting’
2019
Press Release: CBSET’s CEO Peter Markham honored as ‘2019 Biomedical Research Business Leader’ by Massachusetts Society for Medical Research (MSMR)
Endovascular Today: Computational Model Suggests a New Paradigm for Accelerated Treatment Optimization With Paclitaxel Devices
Press Release: Computational model of coating and tissue morphology determinants of balloon based drug retention and tissue dosing suggest a new paradigm for accelerated treatment optimization: CBSET data published in Journal of Controlled Release
Endovascular Today: Computational Model Suggests a New Paradigm for Accelerated Treatment Optimization With Paclitaxel Devices
Press Release: The procedural and anatomical determinants of second-generation renal denervation therapy are explained by local tissue anatomy, suggesting a new paradigm for treatment optimization: CBSET data published in Hypertension
CRT19 Best Innovation Competition: Enhanced Plaque Modification of Cadaveric Human Calcified Peripheral Arteries Treated with a Vessel Preparation System
Not a Single Drug Is Approved to Treat Hearing Loss, but Now There Is Hope
2018
Press Release: CBSET partner CILcare leads Phase 2 of $2.1 million total DETECT project to develop a preclinical model for tinnitus drug therapy development
Press Release: Preclinical safety studies demonstrate that drug presence can accentuate pathological responses at stent fracture sites
Press Release: Study Validates New Approach for Optimizing Endovascular Drug Delivery Using Stents with a Deployable Coating That Enhances Sirolimus Distribution Compared to Traditional DES
Press Release: Preclinical safety studies must include equally balanced male/female animal models to shed light on sex-dependent vascular responses in humans
Press Release: CILcare’s age-related hearing loss model enriched with NAC as positive control
2017
Press Release: CILcare, CBSET, and Draper partner to accelerate hearing loss treatment and care
Press Release: CBSET Chairman Elazer Edelman, MD, PhD, has received the “TCT 2017 Career Achievement Award”
Press Release: Lesion Preparation Using Diamondback 360® Orbital Atherectomy System Enhances Paclitaxel Distribution in Calcified Peripheral Arteries: CBSET Data Published in Journal of Controlled Release
Endovascular Today: Lesion Preparation Using Diamondback 360 OAS Shown to Enhance Paclitaxel Distribution in Calcified PAD
Press Release: CBSET and CILcare partner to offer cutting-edge preclinical research services for the evaluation of hearing disorders and regenerative therapies
Press Release: CBSET expands its preclinical research services by adding GLP-compliant cell-based-therapies support capability
Press Release: Safety and Efficacy of New Class of Orthopedic Implant for Intramedullary Biologic Stabilization of Fractured Long Bones Studied Out to 1 Year
2016
Press Release: CBSET appoints Rami Tzafriri PhD as Director of Research and Innovation
Press Release: CBSET appoints Michael Naimark as Director of Business Development
News Advisory: You Need To Know: Endovascular Drug Delivery Is Experiencing a Resurgence in Innovation
Press Release: A Paradigm for Safety Assessment of Energy-Based Devices: CBSET Presents In Vivo Data at SoT 2016
2015
Press Release: MANTA Vascular Closure Device Safely and Effectively Closes Large Bore Arterial Access Sites: CBSET to Present Preclinical Data at ICI 2015
Press Release: Data provides new insights into the optimal balance between drug-eluting stent coating material properties and drug elution kinetics
Press Release: Primary lesion treatment using Diamondback 360® orbital atherectomy system enhances paclitaxel deposition in calcified peripheral arteries: preclinical data presented at EuroPCR 2015
Endovascular Today: Preclinical Study Evaluates Primary Lesion Treatment With CSI’s Orbital Atherectomy System Before Drug Delivery in Calcified PAD
Press Release: Roadmap for the revitalization of catheter-based renal sympathetic denervation related to clinically meaningful, optimized device design: CBSET to present compelling preclinical evidence at EuroPCR 2015
Press Release: Variable patient responses to catheter-based renal denervation therapy is explained by local tissue anatomy – suggesting a paradigm for treatment optimization: CBSET data published in Science Translational Medicine
Endovascular Today: Study Suggests That Local Tissue Anatomy May Explain Variable Patient Responses to RDN Therapy
Press Release: New Class of Orthopedic Implants for Intramedullary Biologic Fixation of Fractured Long Bones Validated in Preclinical Models – CBSET, IlluminOss Medical Data Published in Journal of Biomedical Materials Research
Press Release: Optimal tissue debulking protocol defined for treating in-stent restenosis (ISR) with Boston Scientific’s JETSTREAM® Navitus atherectomy device
Press Release: Modification of atherosclerotic plaque with Diamondback360® orbital atherectomy device improves drug uptake in peripheral arteries
2014
Press Release: Dr. Haim Danenberg joins CBSET as Chief Scientific Adviser
Press Release: Clinical Efficacy of Renal Denervation Therapies is Related to Innervation Patterns, Microanatomical Structures, and Treatment Paradigms: CBSET to Present Further Mechanistic Evidence at ‘TCT 2014’
Press Release: Efficacy of renal denervation using thermal ablation technologies is dependent on microanatomy: CBSET to present preclinical evidence at EuroPCR 2014
DAIC: CBSET Scientists Indicate Preclinical Research is Critical to the Future of Renal Denervation
Press Release: CBSET scientists indicate mechanistic preclinical research is critical to the future of renal denervation
2013
Press Release: CBSET expands capabilities for high-speed, high-resolution 3D image-guided interventions in the preclinical development of cardiovascular therapies
DAIC: CBSET Presents Preclinical Development Data on Renal Denervation Devices
Press Release: CBSET to present new paradigm at ‘TCT 2013’ for the preclinical development of renal denervation devices
CBSET Events
MEDevice Boston 2026, August 26, 27, Boston, MA
16th American Drug Delivery and Formulation Summit, Sept 14, 15, Boston, MA
Safety Pharmacology Society (SPS) 2026 Annual Meeting, Sept. 21-23, Montreal, Canada
RESI Boston Conference, Sept 22-23, Boston, MA
TCT 2026, October 31-Nov 3, San Diego, CA
ACT Annual Meeting, Nov 15-18, 2026, San Antonio, TX